Get the Latest Investment Ideas Delivered Straight to Your Inbox. Subscribe


Virtual Healthcare Tech Firm's Contract in Puerto Rico Is Its Largest by 400%

Share on Stocktwits


Reliq Health Technologies' agreement with digiiMED makes its platform available to more than 200,000 patients.

Reliq Health Technologies Inc. (RHT:TSX.V; RQHTF:OTCQB), a technology company that develops innovative mobile health and telemedicine solutions for community-based healthcare, announced that it has signed a contract with digiiMed LLC to provide telehealth services to its Medicare and private insurance patients in Puerto Rico.

digiiMED has access to more than 200,000 chronic disease patients "who will benefit greatly from Reliq's iUGO Care Remote Patient Monitoring (RPM), Chronic Care Management (CCM), Behavioral Health Integration (BHI) and Principal Care Management (PCM) solutions," said Jose Alvarez, CEO of digiiMED and Surgical Solutions Puerto Rico.

Reliq's largest prior contract was for 50,000 patients, so the digiiMED agreement represents a 400% increase in patient population in one contract.

"We selected Reliq as our technology partner and iUGO Care as the software platform for our clients after an extensive review of all commercially available digital health solutions," Alvarez stated. "Reliq's iUGO Care platform has the most comprehensive capabilities of any virtual care software solution, but is also intuitive and easy to use for both clinicians and patients."

"Half of all adults in Puerto Rico have at least one chronic condition, over 42% of the population have hypertension and over 16% suffer from diabetes. In the midst of a global pandemic that is overwhelming healthcare systems in states like Texas, Florida and Georgia, it is vital that areas like Puerto Rico protect their high risk chronic disease populations through virtual care programs like iUGO Care's RPM, CCM, BHI and PCM," Lisa Crossley, Reliq's CEO, noted.

"Keeping chronic disease patients healthy and at home reduces the risk of exposure to the virus for this vulnerable group, limiting the spread of the virus in the total population and helping to keep the healthcare system functioning for all of the citizens of Puerto Rico," Crossley stated. "Many communities in Puerto Rico face infrastructure challenges similar to those we address with our remote and rural clients in Canada and the mainland U.S., such as lack of conventional internet connections and limited access to in‐home care, so Reliq is uniquely positioned to meet the needs of this market. digiiMED is a leading healthcare solution provider in Puerto Rico with a proven understanding of the local market and an extensive network of care providers and patients on the island."

Alvarez noted that "Reliq's highly qualified, experienced clinical team was able to help us develop a customized Care Management program that will meet the specific needs of our client populations. Having access to Reliq's existing Spanish‐speaking Care Management and Implementation teams in Texas and Florida will enable digiiMED to onboard physicians and patients immediately while we expand our own customer support team in Puerto Rico."

Reliq notes that the iUGO Care platform "supports care coordination and community‐based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real‐time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits." [NLINSERT]

1) Patrice Fusillo compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Reliq Health Technologies, a company mentioned in this article.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.

Want to read more about Life Sciences Tools & Diagnostics and Healthcare Services investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe